Physician

Abhijana Karunakaran

According to 2025 Medicare claims, Abhijana Karunakaran (NPI: 1093155665) practices endocrinology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is KALEIDA HEALTH (NPI: 1053441907; TIN: 161533232) and primary practice location at 14221-3647. Karunakaran is affiliated with the Optimum NY Independent Practice Association, LLC (ACO ID: D0294), participating under the REACH model.

Karunakaran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 79 traditional Medicare patients, billed 339 HCPCS/CPT codes, and received $18,746 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,423 prescription claims across 296 beneficiaries totaling $1,273,240 in drug costs, led by Ozempic (Semaglutide). DME data shows 112 claims. Open Payments data shows 1 records totaling $106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $29,308 to $1,273,240. For DME billing, reported payments rose steadily, from $1,945 to $23,808.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	125	137	$8,794
2019	285	456	$30,021
2020	211	535	$32,387
2021	247	596	$41,819
2022	161	286	$18,989
2023	152	352	$22,435
2024	79	339	$18,746

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	100	315	$29,308
2016	66	249	$38,363
2017	78	570	$132,774
2018	181	836	$240,222
2019	380	2,387	$1,138,865
2020	457	3,774	$1,868,728
2021	424	4,810	$2,493,419
2022	392	4,560	$2,133,724
2023	388	4,656	$2,219,332
2024	296	3,423	$1,273,240

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	11	27	$411
2019	65	173	$6,108
2020	95	378	$22,661
2021	108	467	$43,617
2022	80	399	$45,650
2023	63	267	$33,773
2024	29	112	$23,345

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	21	27	$97
99443	Telephone medical discussion with physician, 21-30 minutes	33	52	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	59	138	$68
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	12	25	$27
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	56	95	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	272	10,150	$326,953
Jardiance	Empagliflozin	215	10,082	$193,552
Trulicity	Dulaglutide	154	5,012	$163,668
Mounjaro	Tirzepatide	131	4,452	$158,008
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	165	11,273	$29,674

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	14	50	$22,611
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	15	51	$724
A4259	Lancets, per box of 100	N	N/R	11	$10

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$106	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhijana Karunakaran?

Tedicare shows public-source Medicare data for Abhijana Karunakaran (NPI 1093155665), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhijana Karunakaran have ACO affiliation data?

Abhijana Karunakaran is shown with ACO affiliation data for Optimum NY Independent Practice Association, LLC (REACH, ACO ID D0294).

What billing organization is linked to Abhijana Karunakaran?

Abhijana Karunakaran is linked to KALEIDA HEALTH (billing NPI 1053441907) in the available physician profile data.

Does Abhijana Karunakaran have Open Payments data?

Abhijana Karunakaran has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.